Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study
Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment amon...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Felix, Ashley S. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
41321 |
|---|
| Übergeordnetes Werk: |
Enthalten in: IS - Domingues, Sara ELSEVIER, 2018, AJOG, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:219 ; year:2018 ; number:5 ; pages:4591-45911 ; extent:41321 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ajog.2018.08.002 |
|---|
| Katalog-ID: |
ELV044560133 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV044560133 | ||
| 003 | DE-627 | ||
| 005 | 20230624111502.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181113s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajog.2018.08.002 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica |
| 035 | |a (DE-627)ELV044560133 | ||
| 035 | |a (ELSEVIER)S0002-9378(18)30654-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 100 | 1 | |a Felix, Ashley S. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study |
| 264 | 1 | |c 2018 | |
| 300 | |a 41321 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. | ||
| 650 | 7 | |a racial differences |2 Elsevier | |
| 650 | 7 | |a endometrial cancer |2 Elsevier | |
| 650 | 7 | |a adjuvant treatment |2 Elsevier | |
| 650 | 7 | |a tumor heterogeneity |2 Elsevier | |
| 700 | 1 | |a Cohn, David E. |4 oth | |
| 700 | 1 | |a Brasky, Theodore M. |4 oth | |
| 700 | 1 | |a Zaino, Richard |4 oth | |
| 700 | 1 | |a Park, Kay |4 oth | |
| 700 | 1 | |a Mutch, David G. |4 oth | |
| 700 | 1 | |a Creasman, William T. |4 oth | |
| 700 | 1 | |a Thaker, Premal H. |4 oth | |
| 700 | 1 | |a Walker, Joan L. |4 oth | |
| 700 | 1 | |a Moore, Richard G. |4 oth | |
| 700 | 1 | |a Lele, Shashikant B. |4 oth | |
| 700 | 1 | |a Guntupalli, Saketh R. |4 oth | |
| 700 | 1 | |a Downs, Levi S. |4 oth | |
| 700 | 1 | |a Nagel, Christa I. |4 oth | |
| 700 | 1 | |a Boggess, John F. |4 oth | |
| 700 | 1 | |a Pearl, Michael L. |4 oth | |
| 700 | 1 | |a Ioffe, Olga B. |4 oth | |
| 700 | 1 | |a Randall, Marcus E. |4 oth | |
| 700 | 1 | |a Brinton, Louise A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Domingues, Sara ELSEVIER |t IS |d 2018 |d AJOG |g Orlando, Fla |w (DE-627)ELV000288284 |
| 773 | 1 | 8 | |g volume:219 |g year:2018 |g number:5 |g pages:4591-45911 |g extent:41321 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajog.2018.08.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 219 |j 2018 |e 5 |h 4591-45911 |g 41321 |y 219.2018, 5, 459.e1-, (41321 S.) | ||
| author_variant |
a s f as asf |
|---|---|
| matchkey_str |
felixashleyscohndavidebraskytheodoremzai:2018----:eepoajvnedmtilacrramnacrigoaenroclggn |
| hierarchy_sort_str |
2018 |
| publishDate |
2018 |
| allfields |
10.1016/j.ajog.2018.08.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica (DE-627)ELV044560133 (ELSEVIER)S0002-9378(18)30654-9 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Felix, Ashley S. verfasserin aut Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study 2018 41321 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity Elsevier Cohn, David E. oth Brasky, Theodore M. oth Zaino, Richard oth Park, Kay oth Mutch, David G. oth Creasman, William T. oth Thaker, Premal H. oth Walker, Joan L. oth Moore, Richard G. oth Lele, Shashikant B. oth Guntupalli, Saketh R. oth Downs, Levi S. oth Nagel, Christa I. oth Boggess, John F. oth Pearl, Michael L. oth Ioffe, Olga B. oth Randall, Marcus E. oth Brinton, Louise A. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:219 year:2018 number:5 pages:4591-45911 extent:41321 https://doi.org/10.1016/j.ajog.2018.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 219 2018 5 4591-45911 41321 219.2018, 5, 459.e1-, (41321 S.) |
| spelling |
10.1016/j.ajog.2018.08.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica (DE-627)ELV044560133 (ELSEVIER)S0002-9378(18)30654-9 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Felix, Ashley S. verfasserin aut Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study 2018 41321 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity Elsevier Cohn, David E. oth Brasky, Theodore M. oth Zaino, Richard oth Park, Kay oth Mutch, David G. oth Creasman, William T. oth Thaker, Premal H. oth Walker, Joan L. oth Moore, Richard G. oth Lele, Shashikant B. oth Guntupalli, Saketh R. oth Downs, Levi S. oth Nagel, Christa I. oth Boggess, John F. oth Pearl, Michael L. oth Ioffe, Olga B. oth Randall, Marcus E. oth Brinton, Louise A. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:219 year:2018 number:5 pages:4591-45911 extent:41321 https://doi.org/10.1016/j.ajog.2018.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 219 2018 5 4591-45911 41321 219.2018, 5, 459.e1-, (41321 S.) |
| allfields_unstemmed |
10.1016/j.ajog.2018.08.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica (DE-627)ELV044560133 (ELSEVIER)S0002-9378(18)30654-9 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Felix, Ashley S. verfasserin aut Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study 2018 41321 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity Elsevier Cohn, David E. oth Brasky, Theodore M. oth Zaino, Richard oth Park, Kay oth Mutch, David G. oth Creasman, William T. oth Thaker, Premal H. oth Walker, Joan L. oth Moore, Richard G. oth Lele, Shashikant B. oth Guntupalli, Saketh R. oth Downs, Levi S. oth Nagel, Christa I. oth Boggess, John F. oth Pearl, Michael L. oth Ioffe, Olga B. oth Randall, Marcus E. oth Brinton, Louise A. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:219 year:2018 number:5 pages:4591-45911 extent:41321 https://doi.org/10.1016/j.ajog.2018.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 219 2018 5 4591-45911 41321 219.2018, 5, 459.e1-, (41321 S.) |
| allfieldsGer |
10.1016/j.ajog.2018.08.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica (DE-627)ELV044560133 (ELSEVIER)S0002-9378(18)30654-9 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Felix, Ashley S. verfasserin aut Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study 2018 41321 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity Elsevier Cohn, David E. oth Brasky, Theodore M. oth Zaino, Richard oth Park, Kay oth Mutch, David G. oth Creasman, William T. oth Thaker, Premal H. oth Walker, Joan L. oth Moore, Richard G. oth Lele, Shashikant B. oth Guntupalli, Saketh R. oth Downs, Levi S. oth Nagel, Christa I. oth Boggess, John F. oth Pearl, Michael L. oth Ioffe, Olga B. oth Randall, Marcus E. oth Brinton, Louise A. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:219 year:2018 number:5 pages:4591-45911 extent:41321 https://doi.org/10.1016/j.ajog.2018.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 219 2018 5 4591-45911 41321 219.2018, 5, 459.e1-, (41321 S.) |
| allfieldsSound |
10.1016/j.ajog.2018.08.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica (DE-627)ELV044560133 (ELSEVIER)S0002-9378(18)30654-9 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Felix, Ashley S. verfasserin aut Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study 2018 41321 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity Elsevier Cohn, David E. oth Brasky, Theodore M. oth Zaino, Richard oth Park, Kay oth Mutch, David G. oth Creasman, William T. oth Thaker, Premal H. oth Walker, Joan L. oth Moore, Richard G. oth Lele, Shashikant B. oth Guntupalli, Saketh R. oth Downs, Levi S. oth Nagel, Christa I. oth Boggess, John F. oth Pearl, Michael L. oth Ioffe, Olga B. oth Randall, Marcus E. oth Brinton, Louise A. oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:219 year:2018 number:5 pages:4591-45911 extent:41321 https://doi.org/10.1016/j.ajog.2018.08.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 219 2018 5 4591-45911 41321 219.2018, 5, 459.e1-, (41321 S.) |
| language |
English |
| source |
Enthalten in IS Orlando, Fla volume:219 year:2018 number:5 pages:4591-45911 extent:41321 |
| sourceStr |
Enthalten in IS Orlando, Fla volume:219 year:2018 number:5 pages:4591-45911 extent:41321 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
racial differences endometrial cancer adjuvant treatment tumor heterogeneity |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
IS |
| authorswithroles_txt_mv |
Felix, Ashley S. @@aut@@ Cohn, David E. @@oth@@ Brasky, Theodore M. @@oth@@ Zaino, Richard @@oth@@ Park, Kay @@oth@@ Mutch, David G. @@oth@@ Creasman, William T. @@oth@@ Thaker, Premal H. @@oth@@ Walker, Joan L. @@oth@@ Moore, Richard G. @@oth@@ Lele, Shashikant B. @@oth@@ Guntupalli, Saketh R. @@oth@@ Downs, Levi S. @@oth@@ Nagel, Christa I. @@oth@@ Boggess, John F. @@oth@@ Pearl, Michael L. @@oth@@ Ioffe, Olga B. @@oth@@ Randall, Marcus E. @@oth@@ Brinton, Louise A. @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000288284 |
| dewey-sort |
3570 |
| id |
ELV044560133 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044560133</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624111502.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2018.08.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044560133</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(18)30654-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Felix, Ashley S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">41321</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">racial differences</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">endometrial cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">adjuvant treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">tumor heterogeneity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohn, David E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brasky, Theodore M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zaino, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Kay</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mutch, David G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Creasman, William T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thaker, Premal H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Walker, Joan L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moore, Richard G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lele, Shashikant B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guntupalli, Saketh R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Downs, Levi S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagel, Christa I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boggess, John F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pearl, Michael L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ioffe, Olga B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Randall, Marcus E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brinton, Louise A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:219</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:4591-45911</subfield><subfield code="g">extent:41321</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2018.08.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">219</subfield><subfield code="j">2018</subfield><subfield code="e">5</subfield><subfield code="h">4591-45911</subfield><subfield code="g">41321</subfield><subfield code="y">219.2018, 5, 459.e1-, (41321 S.)</subfield></datafield></record></collection>
|
| author |
Felix, Ashley S. |
| spellingShingle |
Felix, Ashley S. ddc 570 fid BIODIV Elsevier racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study |
| authorStr |
Felix, Ashley S. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000288284 |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 VZ BIODIV DE-30 fid Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity Elsevier |
| topic |
ddc 570 fid BIODIV Elsevier racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity |
| topic_unstemmed |
ddc 570 fid BIODIV Elsevier racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity |
| topic_browse |
ddc 570 fid BIODIV Elsevier racial differences Elsevier endometrial cancer Elsevier adjuvant treatment Elsevier tumor heterogeneity |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d e c de dec t m b tm tmb r z rz k p kp d g m dg dgm w t c wt wtc p h t ph pht j l w jl jlw r g m rg rgm s b l sb sbl s r g sr srg l s d ls lsd c i n ci cin j f b jf jfb m l p ml mlp o b i ob obi m e r me mer l a b la lab |
| hierarchy_parent_title |
IS |
| hierarchy_parent_id |
ELV000288284 |
| dewey-tens |
570 - Life sciences; biology |
| hierarchy_top_title |
IS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000288284 |
| title |
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study |
| ctrlnum |
(DE-627)ELV044560133 (ELSEVIER)S0002-9378(18)30654-9 |
| title_full |
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study |
| author_sort |
Felix, Ashley S. |
| journal |
IS |
| journalStr |
IS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
4591 |
| author_browse |
Felix, Ashley S. |
| container_volume |
219 |
| physical |
41321 |
| class |
570 VZ BIODIV DE-30 fid |
| format_se |
Elektronische Aufsätze |
| author-letter |
Felix, Ashley S. |
| doi_str_mv |
10.1016/j.ajog.2018.08.002 |
| dewey-full |
570 |
| title_sort |
receipt of adjuvant endometrial cancer treatment according to race: an nrg oncology/gynecologic oncology group 210 study |
| title_auth |
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study |
| abstract |
Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. |
| abstractGer |
Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. |
| abstract_unstemmed |
Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
5 |
| title_short |
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study |
| url |
https://doi.org/10.1016/j.ajog.2018.08.002 |
| remote_bool |
true |
| author2 |
Cohn, David E. Brasky, Theodore M. Zaino, Richard Park, Kay Mutch, David G. Creasman, William T. Thaker, Premal H. Walker, Joan L. Moore, Richard G. Lele, Shashikant B. Guntupalli, Saketh R. Downs, Levi S. Nagel, Christa I. Boggess, John F. Pearl, Michael L. Ioffe, Olga B. Randall, Marcus E. Brinton, Louise A. |
| author2Str |
Cohn, David E. Brasky, Theodore M. Zaino, Richard Park, Kay Mutch, David G. Creasman, William T. Thaker, Premal H. Walker, Joan L. Moore, Richard G. Lele, Shashikant B. Guntupalli, Saketh R. Downs, Levi S. Nagel, Christa I. Boggess, John F. Pearl, Michael L. Ioffe, Olga B. Randall, Marcus E. Brinton, Louise A. |
| ppnlink |
ELV000288284 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ajog.2018.08.002 |
| up_date |
2024-07-06T21:48:40.773Z |
| _version_ |
1803867936023117824 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV044560133</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624111502.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2018.08.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000789.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV044560133</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(18)30654-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Felix, Ashley S.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">41321</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Black women with endometrial cancer are more likely to die of their disease compared with white women with endometrial cancer. These survival disparities persist even when disproportionately worse tumor characteristics among black women are accounted. Receipt of less complete adjuvant treatment among black patients with endometrial cancer could contribute to this disparity.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">racial differences</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">endometrial cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">adjuvant treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">tumor heterogeneity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohn, David E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brasky, Theodore M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zaino, Richard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Park, Kay</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mutch, David G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Creasman, William T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thaker, Premal H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Walker, Joan L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moore, Richard G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lele, Shashikant B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guntupalli, Saketh R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Downs, Levi S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagel, Christa I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boggess, John F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pearl, Michael L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ioffe, Olga B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Randall, Marcus E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brinton, Louise A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:219</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:4591-45911</subfield><subfield code="g">extent:41321</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2018.08.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">219</subfield><subfield code="j">2018</subfield><subfield code="e">5</subfield><subfield code="h">4591-45911</subfield><subfield code="g">41321</subfield><subfield code="y">219.2018, 5, 459.e1-, (41321 S.)</subfield></datafield></record></collection>
|
| score |
7.398568 |